Replies to post #49169 on Ethema Health Corp (GRST)

[mrsdoubtfire]

So much much for the markets efficiency theory..... Till it explodes north to fill up the gap between market value and intrinsic value

[Bubae]

You are trying the quarterly flip? It will take more than talk as usual. How about posting those 'Crazy #’s $GRST $$' 😆 Year over year revenue is down 5% and operating income is down 87%. More receivables funding to limp through another quarter. Next quarter they will be paying on that new debt finance deal and the cash flow from the Canadian property is now gone. Up next for 2024 is fixing this narrative and share structure to support that regulation "A" offering. There are many shareholders holding what should be hundreds of millions of 5s at this point. Good luck breaking even in my opinion.

For the quarterly period ended September 30, 2023
https://www.otcmarkets.com/filing/html?id=17070521&guid=3RJ-kns94R7-B3h

Results of operations for the three months ended September 30, 2023 and 2022.

Revenues
Revenues were $1,353,899 and $1,424,943 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $71,044 or 5.0%.

Operating Expenses
Operating expenses were $1,320,371 and $1,169,961 for the three months ended September 30, 2023 and 2022, respectively, an increase of $150,410 or 12.9%.

Operating income
Operating income was $33,528 and $254,982 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $221,454 or 86.9%.


September 15, 2022 Funding

On September 15, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement with Itria Ventures LLC (“Itria”), whereby $320,000 of the Receivables of Evernia were sold to Itria, for gross proceeds of $250,000. The Company also incurred fees of $3,000, resulting in net proceeds of $247,500. The Company is obliged to pay $6,666.67 per week until the amount of $320,000 is paid in full. The guarantor of the funding is a minority shareholder in ATHI.

The Company made weekly cash payments of $6,667 totaling $13,333 on the September 15, 2022 funding. The balance outstanding at September 30, 2023 was $306,667, less unamortized discount of $70,076.